JP2013530236A5 - - Google Patents

Download PDF

Info

Publication number
JP2013530236A5
JP2013530236A5 JP2013518683A JP2013518683A JP2013530236A5 JP 2013530236 A5 JP2013530236 A5 JP 2013530236A5 JP 2013518683 A JP2013518683 A JP 2013518683A JP 2013518683 A JP2013518683 A JP 2013518683A JP 2013530236 A5 JP2013530236 A5 JP 2013530236A5
Authority
JP
Japan
Prior art keywords
alkyl
haloalkyl
halo
cyano
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2013518683A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013530236A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2011/042499 external-priority patent/WO2012003262A1/en
Publication of JP2013530236A publication Critical patent/JP2013530236A/ja
Publication of JP2013530236A5 publication Critical patent/JP2013530236A5/ja
Withdrawn legal-status Critical Current

Links

JP2013518683A 2010-07-01 2011-06-30 Pi3k活性の阻害剤としての複素環式化合物およびその用途 Withdrawn JP2013530236A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US36074310P 2010-07-01 2010-07-01
US61/360,743 2010-07-01
PCT/US2011/042499 WO2012003262A1 (en) 2010-07-01 2011-06-30 Heterocyclic compounds and their use as inhibitors of pi3k activity

Publications (2)

Publication Number Publication Date
JP2013530236A JP2013530236A (ja) 2013-07-25
JP2013530236A5 true JP2013530236A5 (OSRAM) 2014-08-14

Family

ID=44304257

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013518683A Withdrawn JP2013530236A (ja) 2010-07-01 2011-06-30 Pi3k活性の阻害剤としての複素環式化合物およびその用途

Country Status (8)

Country Link
US (1) US8759371B2 (OSRAM)
EP (1) EP2588468B1 (OSRAM)
JP (1) JP2013530236A (OSRAM)
AU (1) AU2011271460B2 (OSRAM)
CA (1) CA2803259A1 (OSRAM)
ES (1) ES2472720T3 (OSRAM)
MX (1) MX2012014996A (OSRAM)
WO (1) WO2012003262A1 (OSRAM)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP20140754T2 (hr) 2009-06-29 2015-07-17 Incyte Corporation Pirimidinoni kao inhibitori pi3k
US8759359B2 (en) 2009-12-18 2014-06-24 Incyte Corporation Substituted heteroaryl fused derivatives as PI3K inhibitors
WO2011130342A1 (en) 2010-04-14 2011-10-20 Incyte Corporation FUSED DERIVATIVES AS ΡI3Κδ INHIBITORS
US9062055B2 (en) 2010-06-21 2015-06-23 Incyte Corporation Fused pyrrole derivatives as PI3K inhibitors
WO2012087881A1 (en) 2010-12-20 2012-06-28 Incyte Corporation N-(1-(substituted-phenyl)ethyl)-9h-purin-6-amines as pi3k inhibitors
WO2012125629A1 (en) 2011-03-14 2012-09-20 Incyte Corporation Substituted diamino-pyrimidine and diamino-pyridine derivatives as pi3k inhibitors
WO2012135009A1 (en) 2011-03-25 2012-10-04 Incyte Corporation Pyrimidine-4,6-diamine derivatives as pi3k inhibitors
LT3196202T (lt) 2011-09-02 2019-07-10 Incyte Holdings Corporation Heterociklilaminai, kaip pi3k slopikliai
US20150011569A1 (en) * 2011-12-15 2015-01-08 Philadelphia Health & Education Corporation D/B/A Drexel University College Of Medicine NOVEL P13K p110 INHIBITORS AND METHODS OF USE THEREOF
AR090548A1 (es) 2012-04-02 2014-11-19 Incyte Corp Azaheterociclobencilaminas biciclicas como inhibidores de pi3k
CN104870017B (zh) 2012-11-08 2020-08-14 理森制药股份公司 含有PDE4抑制剂和PI3δ或双重PI3δ-γ激酶抑制剂的药物组合物
EP3008073B1 (en) 2013-06-11 2020-01-01 Latvian Institute Of Organic Synthesis Thieno[2,3-b]pyridines as multidrug resistance modulators
US10077277B2 (en) 2014-06-11 2018-09-18 Incyte Corporation Bicyclic heteroarylaminoalkyl phenyl derivatives as PI3K inhibitors
US9944639B2 (en) 2014-07-04 2018-04-17 Lupin Limited Quinolizinone derivatives as PI3K inhibitors
BR112017003745A2 (pt) 2014-08-29 2017-12-05 Tes Pharma S R L inibidores de semialdeído descarboxilase de ácido alfa-amino-beta-carboximucônico
WO2016054491A1 (en) 2014-10-03 2016-04-07 Infinity Pharmaceuticals, Inc. Heterocyclic compounds and uses thereof
CN117736209A (zh) 2015-02-27 2024-03-22 因赛特控股公司 Pi3k抑制剂的盐及其制备方法
US9732097B2 (en) 2015-05-11 2017-08-15 Incyte Corporation Process for the synthesis of a phosphoinositide 3-kinase inhibitor
WO2016183063A1 (en) 2015-05-11 2016-11-17 Incyte Corporation Crystalline forms of a pi3k inhibitor
US12084472B2 (en) 2015-12-18 2024-09-10 Ardelyx, Inc. Substituted 4-phenyl pyridine compounds as non-systemic TGR5 agonists
TWI773657B (zh) 2015-12-18 2022-08-11 美商亞德利克斯公司 作爲非全身tgr5促效劑之經取代之4-苯基吡啶化合物
WO2017214269A1 (en) 2016-06-08 2017-12-14 Infinity Pharmaceuticals, Inc. Heterocyclic compounds and uses thereof
TW201813963A (zh) 2016-09-23 2018-04-16 美商基利科學股份有限公司 磷脂醯肌醇3-激酶抑制劑
TW201825465A (zh) 2016-09-23 2018-07-16 美商基利科學股份有限公司 磷脂醯肌醇3-激酶抑制劑
TW201815787A (zh) 2016-09-23 2018-05-01 美商基利科學股份有限公司 磷脂醯肌醇3-激酶抑制劑
PE20211208A1 (es) 2018-06-01 2021-07-05 Incyte Corp Regimen de dosificacion para el tratamiento de trastornos relacionados con pi3k

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT72878B (en) 1980-04-24 1983-03-29 Merck & Co Inc Process for preparing mannich-base hydroxamic acid pro-drugs for the improved delivery of non-steroidal anti-inflammatory agents
DE3020458C2 (de) 1980-05-29 1986-07-31 Herzog, Thomas, Prof. Dr., 3500 Kassel Vorgehängte Fassaden-, Bau- oder Dekorationsplatte
US6043062A (en) 1995-02-17 2000-03-28 The Regents Of The University Of California Constitutively active phosphatidylinositol 3-kinase and uses thereof
GB9611460D0 (en) 1996-06-01 1996-08-07 Ludwig Inst Cancer Res Novel lipid kinase
US5858753A (en) 1996-11-25 1999-01-12 Icos Corporation Lipid kinase
US5822910A (en) 1997-10-02 1998-10-20 Shewmake; I. W. Fishing line tensioning device
US7705018B2 (en) * 2007-03-23 2010-04-27 Amgen Inc. Substituted quinolines and their uses in treatment of inflammatory and related conditions
AU2008231304B2 (en) * 2007-03-23 2011-05-12 Amgen Inc. Heterocyclic compounds and their uses
MX2010003449A (es) 2007-09-26 2010-04-27 Astellas Pharma Inc Derivado de quinolona.
US8703778B2 (en) * 2008-09-26 2014-04-22 Intellikine Llc Heterocyclic kinase inhibitors
GB0821693D0 (en) 2008-11-27 2008-12-31 Ucb Pharma Sa Therapeutic agents
WO2010092340A1 (en) 2009-02-13 2010-08-19 Ucb Pharma S.A. Fused pyridine and pyrazine derivatives as kinase inhibitors

Similar Documents

Publication Publication Date Title
JP2013530236A5 (OSRAM)
JP2013533883A5 (OSRAM)
JP2013533884A5 (OSRAM)
JP2013530238A5 (OSRAM)
HRP20160350T1 (hr) Heterociklički spojevi i njihove uporabe
JP2015536307A5 (OSRAM)
JP2011502994A5 (OSRAM)
JP2018520161A5 (OSRAM)
JP2015527401A5 (OSRAM)
JP2012526131A5 (OSRAM)
JP2016534134A5 (OSRAM)
JP2017512833A5 (OSRAM)
JP2015535277A5 (OSRAM)
JP2019527230A5 (OSRAM)
JP2015143283A5 (OSRAM)
RU2014128307A (ru) Пиррольное производное шестичленного гетероарильного кольца, способ его получения и его медицинское применение
JP2017508816A5 (OSRAM)
JP2016510758A5 (OSRAM)
ME02754B (me) Ligandi opioidnih receptora i postupci njihove upotrebe i pripreme
RU2014110623A (ru) Пирролопиразиновые ингибиторы киназы
JP2013523614A5 (OSRAM)
JP2016518385A5 (OSRAM)
JP2010280669A5 (OSRAM)
JP2016537368A5 (OSRAM)
JP2017509689A5 (OSRAM)